Reuters - Swiss drugmaker Roche
Holding AG offered to acquire all outstanding shares
in its U.S. partner Genentech Inc for $43.7 billion in
cash to reinforce its position in cancer medicines.
View the entire article:
Roche offers to buy out Genentech for $43.7 billion
(Reuters)